search
Back to results

Evaluating an Internet-Based Self-Management Intervention for Borderline (REVISIT)

Primary Purpose

Borderline Personality Disorder

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Priovi
CAU
Sponsored by
Gaia AG
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Borderline Personality Disorder

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Psychiatric diagnosis of BPD
  • BPDSI score of 15 or higher
  • Informed consent
  • German language proficiency
  • Willingness to participate in diagnostic and follow-up assessments as well as to see a -
  • Psychiatrist for validation of diagnosis
  • 18 years or older

Exclusion Criteria:

  • Psychotic disorder
  • Primary psychiatric diagnosis of an addictive disorder
  • Schizotypal personality disorder

Sites / Locations

  • Gaia AG

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Priovi

Care-as-Usual (CAU) / wait list

Arm Description

Priovi is an Internet-administered intervention for people with BPD.

Additionaly, they will be informed about helpful and free available online self-help-proposals for BPD patients immediately after randomization.

Outcomes

Primary Outcome Measures

Score of the Borderline Personality Disorder Severity Index (BPDSI) - The BPDSI is a semi-structured interview assessing the frequency and severity of manifestations of borderline personality disorder (BPD) during the last three months.
Semi-structured interview assessing BPD symptom frequency and severity

Secondary Outcome Measures

Severity of depressive symptoms, measured by Patient Health Questionnaire - 9 items (PHQ-9)
Self-report depression symptom severity measure. Nine items, each of which is scored 0 to 3, providing a 0 to 27 severity score. Depression Severity: 0-4 none, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe.
GAD-7 (Generalized Anxiety Disorder Questionnaire)
Self-report anxiety symptom severity measure. Seven items, each of which is scored 0 to 3, providing a 0 to 21 severity score. Anxiety Severity: 0-4 none, 5-9 mild, 10-14 moderate, 15-21 severe.
EQ-5D (standardized instrument developed by the EuroQol Group as a measure of health-related quality of life.)
Self-report measure of quality of life symptoms.
BPD-Checklist short (Borderline personality Disorder Checklist short)
Self-report measure of BPD symptoms.
2 Items of CIUS-Long-brief (Compulsive Internet Use Scale)
Adapted self-report measure assessing potential compulsive internet use. two items, each of which is scored 1 to 5, providing a 2 to 10 severity score with higher values representing a worse outcome
NEQ (negative effects questionnaire)
Self-report measure of potential negative effects of the treatment. qualitative measure.

Full Information

First Posted
January 23, 2018
Last Updated
February 21, 2020
Sponsor
Gaia AG
Collaborators
University of Luebeck
search

1. Study Identification

Unique Protocol Identification Number
NCT03418142
Brief Title
Evaluating an Internet-Based Self-Management Intervention for Borderline
Acronym
REVISIT
Official Title
Research Evaluating the EffectiVeness of Adding an Internet-Based Self-Management Intervention to Usual Care in the Treatment of Borderline Personality Disorder - REVISIT BPD
Study Type
Interventional

2. Study Status

Record Verification Date
February 2020
Overall Recruitment Status
Completed
Study Start Date
January 29, 2018 (Actual)
Primary Completion Date
January 29, 2020 (Actual)
Study Completion Date
January 29, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Gaia AG
Collaborators
University of Luebeck

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The trial aims to evaluate the effectiveness of a novel internet intervention (Priovi), which was designed to introduce relevant schema therapy techniques to Persons with Borderline Personality Disorder (BPD). Therefore, 200 people with BPD will be recruited and randomized to two groups: (1) a control group, in which they may engage with any BPD treatment (Care-as-Usual, CAU) and receive access to Priovi after a delay of 12 months (i.e., CAU/wait list control group), or (2) to a treatment group that immediately receives 12-month access to Priovi and may also use CAU. The primary outcome measure is the score of the Borderline Personality Disorder Severity Index (BPDSI), collected at three, six and 12 month post-baseline.
Detailed Description
In the treatment of psychological disorders, web-based self-help programs can be very helpful, especially when combined with psychotherapy. However, up to this point, there are no respective programs for patients with Borderline Personality Disorder (BPD), although this disorder is associated with severe personal suffering and requires time-consuming therapy, which, in many cases, cannot be provided, due to the lack of therapeutic supply. In this study, treatment effects of the web-based self-help program Priovi on BPD symptom severity when added to treatment as usual will be investigated. Priovi is a comprehensive program, which is conceptually and substantially based on the schema therapeutic approach used in BPD patients. It contains interactive dialogues that can be accessed via computer or smartphone, illustrations, audios and motivating text messages. After a phone pre-screen and a diagnostic evaluation conducted by a psychiatrist, 200 patients suffering from BPD will be randomized into either the intervention group or into the waitlist control group. Priovi's duration of use is one year, measuring points will be determined before beginning of treatment (T0) as well as after 3 (T1), 6 (T2), 9 (T3) and 12 months (T4). The primary outcome variable will be the score of the Borderline Personality Disorder Severity Index (BPDSI), a highly reliable external assessment tool measuring BPD severity. Secondary outcome variables will be BPD symptom severity (as assessed by self-ratings), symptom severity of depression and anxiety as well as quality of life. The study will be collaboratively conducted by the University of Lübeck and the GAIA AG in Hamburg. In this study, Priovi for BPD patients will be tested in a randomized controlled trial. It will be used as add-on therapy combined with any guideline therapy available to the respective patients. In doing so, the following hypothesis will be investigated: Compared to patients, who exclusively receive treatment as usual, the additional use of the self-help program in question will lead to a stronger decrease in BPD symptom severity.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Borderline Personality Disorder

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
206 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Priovi
Arm Type
Experimental
Arm Description
Priovi is an Internet-administered intervention for people with BPD.
Arm Title
Care-as-Usual (CAU) / wait list
Arm Type
Active Comparator
Arm Description
Additionaly, they will be informed about helpful and free available online self-help-proposals for BPD patients immediately after randomization.
Intervention Type
Behavioral
Intervention Name(s)
Priovi
Intervention Description
Priovi is an Internet intervention for people with BPD. Content is continuously adapted to patients' concerns and needs. Priovi is a comprehensive program, which is conceptually and substantially based on the schema therapeutic approach used in BPD patients. It contains interactive dialogues that can be accessed via computer or smartphone, illustrations, audios and motivating text messages. Techniques to cope with borderline symptoms (e.g., psychoeducation about modes, schemas and basic emotional needs in addition to relevant strategies to weaken, reduce and/or heal maladaptive schemas and modes) are conveyed in interactive sequences that are accompanied by audio recordings, illustrations, and worksheets. Patients are also prompted to regularly complete brief symptom severity self-monitoring questionnaires. Optional daily text messages with motivational content accompany the program. The program can be accessed for 365 days after registration.
Intervention Type
Other
Intervention Name(s)
CAU
Intervention Description
Care as Usual: In the CAU/wait list control group, participants are free to continue to engage with any treatment they require (i.e., CAU). However, they will receive access to Priovi after 12 months post-baseline (i.e., wait list with respect to Priovi access).
Primary Outcome Measure Information:
Title
Score of the Borderline Personality Disorder Severity Index (BPDSI) - The BPDSI is a semi-structured interview assessing the frequency and severity of manifestations of borderline personality disorder (BPD) during the last three months.
Description
Semi-structured interview assessing BPD symptom frequency and severity
Time Frame
Changes from baseline to 3, 6 and 12 months
Secondary Outcome Measure Information:
Title
Severity of depressive symptoms, measured by Patient Health Questionnaire - 9 items (PHQ-9)
Description
Self-report depression symptom severity measure. Nine items, each of which is scored 0 to 3, providing a 0 to 27 severity score. Depression Severity: 0-4 none, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe.
Time Frame
Changes from baseline to 3, 6, 9 and 12 months.
Title
GAD-7 (Generalized Anxiety Disorder Questionnaire)
Description
Self-report anxiety symptom severity measure. Seven items, each of which is scored 0 to 3, providing a 0 to 21 severity score. Anxiety Severity: 0-4 none, 5-9 mild, 10-14 moderate, 15-21 severe.
Time Frame
Changes from baseline to 3, 6, 9 and 12 months.
Title
EQ-5D (standardized instrument developed by the EuroQol Group as a measure of health-related quality of life.)
Description
Self-report measure of quality of life symptoms.
Time Frame
Changes from baseline to 3, 6, 9 and 12 months.
Title
BPD-Checklist short (Borderline personality Disorder Checklist short)
Description
Self-report measure of BPD symptoms.
Time Frame
Changes from baseline to 3, 6, 9 and 12 months.
Title
2 Items of CIUS-Long-brief (Compulsive Internet Use Scale)
Description
Adapted self-report measure assessing potential compulsive internet use. two items, each of which is scored 1 to 5, providing a 2 to 10 severity score with higher values representing a worse outcome
Time Frame
Assessed at 3, 6, 9 and 12 months.
Title
NEQ (negative effects questionnaire)
Description
Self-report measure of potential negative effects of the treatment. qualitative measure.
Time Frame
Assessed at baseline, 3, 6, 9 and 12 months.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Psychiatric diagnosis of BPD BPDSI score of 15 or higher Informed consent German language proficiency Willingness to participate in diagnostic and follow-up assessments as well as to see a - Psychiatrist for validation of diagnosis 18 years or older Exclusion Criteria: Psychotic disorder Primary psychiatric diagnosis of an addictive disorder Schizotypal personality disorder
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jan Philipp Klein, Dr. med.
Organizational Affiliation
University of Lübeck, Zentrum für Integrative Psychiatrie ZiP gGmbH
Official's Role
Principal Investigator
Facility Information:
Facility Name
Gaia AG
City
Hamburg
ZIP/Postal Code
20144
Country
Germany

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Anonymized individual participant data shall be made available upon request for projects such as meta-analyses after completion of the study
Citations:
PubMed Identifier
34497078
Citation
Klein JP, Hauer-von Mauschwitz A, Berger T, Fassbinder E, Mayer J, Borgwardt S, Wellhofer B, Schweiger U, Jacob G. Effectiveness and safety of the adjunctive use of an internet-based self-management intervention for borderline personality disorder in addition to care as usual: results from a randomised controlled trial. BMJ Open. 2021 Sep 8;11(9):e047771. doi: 10.1136/bmjopen-2020-047771.
Results Reference
derived
PubMed Identifier
32368793
Citation
Storebo OJ, Stoffers-Winterling JM, Vollm BA, Kongerslev MT, Mattivi JT, Jorgensen MS, Faltinsen E, Todorovac A, Sales CP, Callesen HE, Lieb K, Simonsen E. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2020 May 4;5(5):CD012955. doi: 10.1002/14651858.CD012955.pub2.
Results Reference
derived
PubMed Identifier
30298024
Citation
Klein JP, Hauer A, Berger T, Fassbinder E, Schweiger U, Jacob G. Protocol for the REVISIT-BPD Trial, a Randomized Controlled Trial Testing the Effectiveness of an Internet-Based Self-Management Intervention in the Treatment of Borderline Personality Disorder (BPD). Front Psychiatry. 2018 Sep 21;9:439. doi: 10.3389/fpsyt.2018.00439. eCollection 2018.
Results Reference
derived

Learn more about this trial

Evaluating an Internet-Based Self-Management Intervention for Borderline

We'll reach out to this number within 24 hrs